Prosecution Insights
Last updated: October 27, 2026

Erin M Bowers, USPTO Patent Examiner

Listed by the USPTO as BOWERS, ERIN M

Tech Center 1600 • Art Units: 1653 1675 1681 1693

This examiner grants 55% of resolved cases

Analysis

BOWERS, ERIN M works in tech center 1600 and art unit 1653. The record covers 554 resolved cases, with a 54.7% allowance rate and a median of 1286 days to allowance. The 9.8% interview lift shows a positive association between interviews and allowance, but the allowance outcome remains close to an even division of resolved matters.

The leading companies are Promega Corporation, Animal Microbiome Analytics, Inc., and Wisconsin Alumni Research Foundation. The listed firms are Casimir Jones, S.C., BakerHostetler, and PA - BOZICEVIC FIELD & FRANCIS LLP. Practitioners should combine interview preparation with careful claim development and account for the 1286-day median prosecution timeline.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

54.7%
Allow Rate
-5.3% vs TC avg
618
Total Applications
+9.8%
Interview Lift
1286
Avg Prosecution Days
Based on 554 resolved cases, 2023–2026

Rejection Statute Breakdown

6.5%
§101 Eligibility
10.1%
§102 Novelty
46.0%
§103 Obviousness
26.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18611181 TWO COMBINED MUTATIONS THAT INTRODUCE THE SECOND ENTRY PATHWAY TO SYNTHESIZED LIGNIN FROM TYROSINE IN PLANTS Non-Final OA Wisconsin Alumni Research Foundation
18599563 Deep Eutectic Solvent Stabilized Enzyme-Based Electrochemical Assay Probes for Use in the Field Non-Final OA The Government of the United States of America, as represented by the Secretary of the Navy
18669411 METABOLIC AND MICROBIAL BIOMARKERS FOR DETECTION OF PANCREATICOBILIARY CANCERS Non-Final OA Northwestern University
18654695 PROCASPASE-CLEAVING PROTEASES AND USES THEREOF Non-Final OA President and Fellows of Harvard College
18223989 COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME Final Rejection University of Washington
17177591 CELL CULTURE METHOD AND CELL CULTURE APPARATUS Final Rejection NIKKISO CO., LTD.
18355437 Distributed Ribonucleic Acid Manufacturing Via Enzymatic Reaction And Separation Non-Final OA Drexel University
18024955 METHOD FOR DIAGNOSING NONALCOHOLIC STEATOHEPATITIS Final Rejection NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
17920561 METHOD OF REDUCING AND RECYCLING OXIDIZED FLAVIN COFACTORS Final Rejection Oxford University Innovation Limited
18700134 ENDOGLUCANASE WITH IMPROVED STABILITY Non-Final OA Novozymes A/S
18709663 PROTEIN-DEAMIDATING ENZYME Non-Final OA AMANO ENZYME INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Erin M Bowers's allowance rate?

54.7% of resolved applications examined by Erin M Bowers were allowed (554 resolved cases), compared with 23.5% across Art Unit 1653 over the last five years.

Does an interview help with examiner Erin M Bowers?

This examiner's interview lift is +9.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Erin M Bowers take to allow a patent?

Applications allowed by Erin M Bowers took 1,286 days on average from filing to allowance.

Which art unit does examiner Erin M Bowers work in?

Erin M Bowers examines applications in Art Unit 1653 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month